- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A GP received Cialis samples by post via an agency and said he hadn’t requested them. The Panel found the rep had…
AstraZeneca’s Arimidex mailer compared 28‑day acquisition costs of aromatase inhibitors under a broad “breast cancer” heading without clarifying differing licensed indications. PMCPA…
Shire’s journal ad claimed Calcichew-D3 Forte was preferred over Adcal-D3 by 80% of patients and implied a pleasant taste. PMCPA found the…
PMCPA case AUTH/3004/12/17 (Director v Gilead) concerning clinical trial disclosure for Sovaldi. Outcome: no breach; matter found to be outwith the scope…
Amicus presented on investigational migalastat at a UK patient organisation network meeting. PMCPA ruled pre-authorisation promotion and lack of certification (Clauses 3.1,…
A member of the public complained to the PMCPA about Mitsubishi regarding clinical trial disclosure for Incivo. The matter was ruled outwith…
Anonymous complaint about Pfizer meeting sponsorship. PMCPA concluded the matter was outwith the scope of the ABPI Code, so no case report…
Ferriprox banner and patient-newsletter content drew breaches for missing prescribing info link (HCP ad), unsubstantiated hanging comparison, and unbalanced public messaging encouraging…
Anonymous complaint alleged repeated advisory boards were disguised promotion with excessive value. Panel found a breach of Clause 9.1 (high standards) due…
Two health boards said a Cipralex letter implied they endorsed use in GAD. A representative had altered a certified template and sent…
A PCT complained about an emailed invite to an AstraZeneca-sponsored gastroenterology meeting that mentioned Nexium without prescribing information and without the generic…
Doctor challenged Gardasil journal ad claims. Panel initially found one claim ambiguous/misleading, but on appeal the ruling was overturned. Final outcome: no…
A BMJ Symbicort ad headed “Improving survival in COPD” was ruled misleading because it implied Symbicort improved survival, which was not substantiated.…
A Pulse ad for Xarelto implied it could be used “with confidence” in NVAF patients with renal impairment. PMCPA found the claim…
Curaprox complaint about a Corsodyl Mint Mouthwash detail aid. PMCPA found the matter outwith the scope of the Code; no breach. Undertaking…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.